These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. NMDA receptor antagonists and glycine site NMDA antagonists. Madden K Curr Med Res Opin; 2002; 18 Suppl 2():s27-31. PubMed ID: 12365826 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers. Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897 [TBL] [Abstract][Full Text] [Related]
10. NMDA/NR2B selective antagonists in the treatment of ischemic brain injury. Wang CX; Shuaib A Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):143-51. PubMed ID: 15857299 [TBL] [Abstract][Full Text] [Related]
11. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice. Li J; Henman MC; Doyle KM; Strbian D; Kirby BP; Tatlisumak T; Shaw GG Brain Res; 2004 Dec; 1029(1):84-92. PubMed ID: 15533319 [TBL] [Abstract][Full Text] [Related]
12. Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors. Widdowson PS; Gyte AJ; Upton R; Wyatt I Brain Res; 1996 Nov; 738(2):236-42. PubMed ID: 8955518 [TBL] [Abstract][Full Text] [Related]
13. The rise and fall of NMDA antagonists for ischemic stroke. Hoyte L; Barber PA; Buchan AM; Hill MD Curr Mol Med; 2004 Mar; 4(2):131-6. PubMed ID: 15032709 [TBL] [Abstract][Full Text] [Related]
14. Protective use of N-methyl-D-aspartate receptor antagonists as a spinoplegia against excitatory amino acid neurotoxicity. Cho Y; Ueda T; Mori A; Shimizu H; Haga Y; Yozu R J Vasc Surg; 2005 Oct; 42(4):765-71. PubMed ID: 16242566 [TBL] [Abstract][Full Text] [Related]
15. Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions. Jansen M; Dannhardt G Eur J Med Chem; 2003; 38(7-8):661-70. PubMed ID: 12932897 [TBL] [Abstract][Full Text] [Related]
16. A comparison of the effects of a sodium channel blocker and an NMDA antagonist upon extracellular glutamate in rat focal cerebral ischemia. Chen J; Graham SH; Simon RP Brain Res; 1995 Nov; 699(1):121-4. PubMed ID: 8616600 [TBL] [Abstract][Full Text] [Related]
17. A novel N-methyl-D-aspartate receptor open channel blocker with in vivo neuroprotectant activity. Planells-Cases R; Montoliu C; Humet M; Fernández AM; García-Martínez C; Valera E; Merino JM; Pérez-Payá E; Messeguer A; Felipo V; Ferrer-Montiel A J Pharmacol Exp Ther; 2002 Jul; 302(1):163-73. PubMed ID: 12065713 [TBL] [Abstract][Full Text] [Related]
18. The NMDA receptor complex: a long and winding road to therapeutics. Wood PL IDrugs; 2005 Mar; 8(3):229-35. PubMed ID: 15772895 [TBL] [Abstract][Full Text] [Related]
19. The effect of non-competitive N-methyl-D-aspartate receptor antagonism on cerebral oedema and cerebral infarct size in the aging ischaemic brain. Davis M; Perry RH; Mendelow AD Acta Neurochir Suppl; 1997; 70():30-3. PubMed ID: 9416269 [TBL] [Abstract][Full Text] [Related]
20. BQ-869, a novel NMDA receptor antagonist, protects against excitotoxicity and attenuates cerebral ischemic injury in stroke. Yu G; Wu F; Wang ES Int J Clin Exp Pathol; 2015; 8(2):1213-25. PubMed ID: 25973006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]